Insertable Cardiac Monitor Market Size, Share and Trends Analysis | Global | 2025-2032

Global Insertable Cardiac Monitor Market Report

By iData Research - 46 pages - 5 charts, 19 figures

Executive Summary

The global insertable cardiac monitor market was valued at over $1.32 billion in 2025 and is expected to grow at a CAGR of 4.6% to reach nearly $1.81 billion by 2032. Growth is supported by increasing demand for long-term cardiac rhythm monitoring and earlier detection of arrhythmias.
This report follows the same structure and methodology as the provided example, adapted to the insertable cardiac monitor market and its specific clinical use cases . It includes detailed analysis of unit sales, average selling prices, procedural volumes and competitive positioning across global regions.
Cardiovascular disease continues to rise globally, driven by aging populations and increasing prevalence of obesity, diabetes and other metabolic risk factors. The global population over 60 has surpassed 1.2 billion and is expected to approach 1.5 billion by the early 2030s, expanding the patient base for arrhythmia monitoring.
A key driver of market growth is the integration of artificial intelligence into insertable cardiac monitors. Technologies such as Medtronic’s AccuRhythm and Abbott’s Assert-IQ improve diagnostic accuracy by reducing false positives while maintaining sensitivity to clinically significant events, increasing physician confidence and supporting broader adoption.

Market Overview

The global insertable cardiac monitor market consists of implantable devices designed for continuous, long-term monitoring of cardiac rhythm. These devices are typically used in patients with infrequent or unexplained arrhythmias, where traditional external monitoring methods are insufficient.
Insertable cardiac monitors play a critical role in diagnosing conditions such as atrial fibrillation, syncope and cryptogenic stroke. Their ability to provide continuous monitoring over extended periods allows clinicians to capture intermittent events that would otherwise go undetected.
The market is closely tied to trends in cardiovascular disease. As the prevalence of arrhythmias increases with age and comorbid conditions, demand for long-term monitoring solutions continues to grow. Insertable monitors are increasingly used as part of standard diagnostic pathways, particularly in patients at risk of stroke or sudden cardiac events.
Technological advancements are reshaping the market. Devices are becoming smaller, easier to implant and more integrated with remote monitoring platforms. The addition of AI-driven algorithms is improving diagnostic accuracy and reducing clinician workload, positioning insertable cardiac monitors as a key tool in modern cardiac care.

Market Drivers

The insertable cardiac monitor market is driven by the need to reduce mortality associated with cardiovascular disease. With cardiovascular disease remaining the leading cause of death globally, there is strong clinical incentive to detect arrhythmias earlier and initiate appropriate treatment. Insertable monitors provide a reliable method for identifying clinically significant events in high-risk patients.
Advances in arrhythmia detection and treatment are also supporting market growth. As therapies for complex arrhythmias improve, the value of accurate diagnosis increases. Insertable monitors enable detection of infrequent or asymptomatic arrhythmias, which would otherwise remain undiagnosed, leading to increased utilization of these devices.
Artificial intelligence represents the most significant technological driver. AI-enabled detection algorithms reduce false positive alerts while maintaining high sensitivity. This improves workflow efficiency and increases physician confidence in device data, supporting broader adoption across clinical settings.

Market Limiters

The primary limitation of the insertable cardiac monitor market is the high cost of implantation procedures. In 2025, the total cost of an implantation procedure typically ranged from $10,000 to $15,000. This places the procedure outside the budget of many patients, even in developed markets with insurance coverage.
Cost constraints also impact adoption in emerging markets, where reimbursement systems may not fully support the use of insertable monitors. As a result, utilization remains concentrated in higher-income regions and specialized care centers.
Another limitation is the need for clear clinical justification. While insertable monitors provide valuable diagnostic data, their use must be balanced against cost considerations. In some cases, physicians may opt for less expensive external monitoring methods before proceeding to implantation.

Market Coverage and Data Scope

Quantitative Coverage
Market size, market shares, market forecasts, growth rates, units sold and average selling prices.
Qualitative Coverage
Market drivers and limiters, growth trends, competitive analysis, mergers and acquisitions, company profiles and product portfolios.
Time Frame
Base year 2025, historical data to 2022 and forecasts through 2032.
Data Types Included
Unit sales, average selling prices, procedure numbers, market size and growth trends.

Markets Covered and Segmentation

The report covers the Global Insertable Cardiac Monitor Market.
The market is analyzed as a unified segment, reflecting the standardized nature of insertable cardiac monitor technology across clinical applications.
All data is segmented by unit volume, average selling price and market value, with forecasts through 2032.

Competitive Analysis

Medtronic leads the global insertable cardiac monitor market in 2025, supported by its LINQ II and Reveal LINQ systems. The LINQ II platform incorporates advanced AI-driven arrhythmia detection and enhanced remote monitoring capabilities, strengthening Medtronic’s position as the market leader. The Reveal LINQ remains widely used for long-term monitoring due to its minimally invasive design and established clinical performance.
Abbott holds the second-leading position with a portfolio that includes Confirm Rx, Jot Dx and Assert-IQ devices. These systems offer mobile-enabled data transmission and streamlined remote monitoring, supporting efficient patient management. Abbott’s integration of AI-based detection algorithms has improved diagnostic accuracy and strengthened its competitive position.
Boston Scientific ranks third in the market with its LUX-Dx insertable cardiac monitor. The device provides long-term rhythm monitoring and integrates with the company’s broader cardiac rhythm management portfolio. While Boston Scientific maintains a stable position, its market share remains behind the leading competitors.
The competitive landscape is concentrated among a small number of major players with established CRM portfolios. Competition is driven by improvements in diagnostic accuracy, device miniaturization and remote monitoring capabilities.

Technology and Practice Trends

Artificial intelligence is the most important trend shaping the insertable cardiac monitor market. AI-driven algorithms improve detection accuracy and reduce false positive alerts, making devices more reliable and easier to use in clinical practice.
Miniaturization continues to improve patient experience and procedural efficiency. Smaller devices are easier to implant and less invasive, supporting wider adoption.
Remote monitoring is also a key trend. Modern devices transmit data automatically to cloud-based platforms, enabling continuous patient monitoring and reducing the need for in-person follow-up visits.
Integration with broader digital health systems is increasing. Insertable monitors are becoming part of connected care ecosystems, supporting more comprehensive management of cardiovascular patients.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Deliverables

46 pages of detailed market analysis, segmentation and forecasts.
5 charts and 19 figures illustrating key trends and competitive positioning.

Methodology Appendix and Acronym Glossary.

Licensing options include single-user, site and enterprise.

Why This Report

What is driving growth in the global insertable cardiac monitor market?
How is artificial intelligence improving diagnostic accuracy and adoption?
What role do demographic trends play in expanding the patient base?
Which companies lead the market and how strong are their competitive positions?
How do cost and reimbursement challenges impact adoption across regions?
What are the key opportunities for growth through 2032?
The Global Insertable Cardiac Monitor Market Report from iData Research answers these questions with detailed data and analysis. Use it to understand demand, benchmark competitors and plan strategy in a growing segment of cardiac monitoring.

About iData Research

iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC. Show more